{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:11:53Z","timestamp":1792005113414,"version":"4.4.0"},"reference-count":423,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL151498"],"award-info":[{"award-number":["HL151498"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["DP1OD006779"],"award-info":[{"award-number":["DP1OD006779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"HHS | NIH | U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["T15LM012495"],"award-info":[{"award-number":["T15LM012495"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"HHS | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001412"],"award-info":[{"award-number":["UL1TR001412"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010232","name":"National Institute of Development Administration","doi-asserted-by":"publisher","award":["K01DA056690"],"award-info":[{"award-number":["K01DA056690"]}],"id":[{"id":"10.13039\/501100010232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2023,3,23]]},"abstract":"<jats:p>Preventing and controlling influenza virus infection remains a global public health challenge, as it causes seasonal epidemics to unexpected pandemics. These infections are responsible for high morbidity, mortality, and substantial economic impact.<\/jats:p>","DOI":"10.1128\/cmr.00040-22","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T09:01:03Z","timestamp":1673859663000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":163,"title":["Antiviral Approaches against Influenza Virus"],"prefix":"10.1128","volume":"36","author":[{"given":"Rashmi","family":"Kumari","sequence":"first","affiliation":[{"name":"Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"},{"name":"Department of Anesthesiology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh D.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Kumar","sequence":"additional","affiliation":[{"name":"Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Ende","sequence":"additional","affiliation":[{"name":"Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"},{"name":"Oak Ridge Institute for Science and Education (ORISE), CDC Fellowship Program, Oak Ridge, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Mishina","sequence":"additional","affiliation":[{"name":"Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"},{"name":"Association of Public Health Laboratories, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackary","family":"Falls","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Samudrala","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Pohl","sequence":"additional","affiliation":[{"name":"Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Knight","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-5793","authenticated-orcid":true,"given":"Suryaprakash","family":"Sambhara","sequence":"additional","affiliation":[{"name":"Immunology and Pathogenesis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"World Health Organization. 2022. Comparison of number of influenza detections by subtype. https:\/\/app.powerbi.com\/view?r=eyJrIjoiZTIxMzAwMzYtZWE4NC00YTU2LWE3MTUtMTI0OGY1ZjQyMWViIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9. Retrieved 18 February 2022."},{"key":"e_1_3_2_3_2","unstructured":"Centers for Disease Control and Prevention. 2022. Weekly U.S. influenza surveillance report. https:\/\/www.cdc.gov\/flu\/weekly\/index.htm. Retrieved 18 February 2022."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33293-2"},{"key":"e_1_3_2_5_2","unstructured":"Centers for Disease Control and Prevention. 2020. Past seasons estimated influenza disease burden. https:\/\/www.cdc.gov\/flu\/about\/burden\/past-seasons.html?web=1&wdLOR=cEAB96504-2317-493E-BEF7-B9E799A85D55. Retrieved 18 February 2022."},{"key":"e_1_3_2_6_2","unstructured":"Centers for Disease Control and Prevention. 2021. People at higher risk of flu complications https:\/\/www.cdc.gov\/flu\/highrisk\/index.htm. Retrieved 18 February 2022."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1854-x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-012-9796-8"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77679-7"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068665"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01630-0"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12470"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.057"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/v11040346"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003657"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0903810"},{"key":"e_1_3_2_17_2","unstructured":"Centers for Disease Control and Prevention. 2021. Past seasons\u2019 vaccine effectiveness estimates. https:\/\/www.cdc.gov\/flu\/vaccines-work\/past-seasons-estimates.html. Retrieved 18 February 2022."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-153"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy876"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.10.074"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1769-7"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy376"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.08.028"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13061109"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900922"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31999-x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1733830"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716197"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1917378"},{"key":"e_1_3_2_30_2","unstructured":"Centers for Disease Control and Prevention. 2022. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. https:\/\/www.cdc.gov\/flu\/avianflu\/novel-av-treatment-guidance.htm. Retrieved 15 February 2022."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00224-20"},{"key":"e_1_3_2_32_2","first-page":"703","article-title":"Serological evidence for prevention of influenzal infection in volunteers by an anti-influenzal drug adamantanamine hydrochloride","volume":"161","author":"Jackson GG","year":"1963","unstructured":"Jackson GG, Muldoon RL, Akers LW. 1963. Serological evidence for prevention of influenzal infection in volunteers by an anti-influenzal drug adamantanamine hydrochloride. Antimicrob Agents Chemother (Bethesda) 161:703\u2013707.","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.556-559.2005"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67338-2"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1086\/518936"},{"key":"e_1_3_2_36_2","first-page":"433","article-title":"Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"Centers for Disease Control and Prevention. 2009. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 58:433\u2013435.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01417-09"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/mst204"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5816"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00269"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00119-10"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8916"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-008-0292-6"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00559"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.07.039"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01581"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071722"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01319232"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.REV120.013309"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-7651-1_4"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2021.03.001"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.65.1.245-253.1991"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-4-49"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01434-06"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003904"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.14.66"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038398"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00378-11"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(81)90449-9"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.9.5812-5818.2005"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07745"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv333"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.4161\/rna.25356"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-092917-043339"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.12.003"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13102090"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2009.06.003"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2011.07.002"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12070755"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.06.005"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12089"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2018.12.009"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.012"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00320"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.9.4697"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2562"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02367-07"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3056"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12050504"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.670177"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2017.12.006"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10120708"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2006-0283RC"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104747"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.2008\/004606-0"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-78-10-2447"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00319-15"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.32607\/actanaturae.11020"},{"key":"e_1_3_2_90_2","unstructured":"Food and Drug Administration. 2002. Drug approval package. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/99\/18703S56_zantac.cfm. Retrieved 19 February 2022."},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001265.pub2"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.386515"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.5.865"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0910584106"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900312"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.2.216"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90211-9"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070654"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161207782341295"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.62.8.2762-2772.1988"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01184-08"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.08.029"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.1c04660"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705624114"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja508461m"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja4041412"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.3.2449-2455.1998"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.67.9.5585-5594.1993"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06528"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.65.10.5491-5498.1991"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.10.5000"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.8.3647-3656.2001"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009997107"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615471113"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104780"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb07555.x"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.68.2.911-919.1994"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06531"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804958105"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08722"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10858-009-9352-9"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2010.09.014"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi9008837"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja2050666"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.8b06741"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja102581n"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M710302200"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M003663200"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(95)80003-2"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.17.7755-7761.2000"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.21.11301"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.03.026"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.8.joc60020"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119115"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.119.116640"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1002\/prot.20018"},{"key":"e_1_3_2_137_2","first-page":"395","article-title":"Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic","volume":"25","author":"Heider H","year":"1981","unstructured":"Heider H, Adamczyk B, Presber HW, Schroeder C, Feldblum R, Indulen MK. 1981. Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic. Acta Virol 25:395\u2013400.","journal-title":"Acta Virol"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.5.969"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1086\/504723"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105124"},{"key":"e_1_3_2_141_2","unstructured":"Centers for Disease Control and Prevention. 2006. CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 2005\u201306 influenza season. https:\/\/stacks.cdc.gov\/view\/cdc\/25151. Retrieved 21 February 2022."},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-019-0371-2"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607614103"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-70227-3_5"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2400"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1038\/363418a0"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-440x(96)80014-5"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-33-1-159"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(74)90458-9"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(74)90080-4"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1038\/303035a0"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2001.1021"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1626824"},{"key":"e_1_3_2_154_2","unstructured":"Food and Drug Administration. 2012. Highlights of prescribing information (Tamiflu). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/021087s062lbl.pdf. Retrieved 21 February 2022."},{"key":"e_1_3_2_155_2","unstructured":"Centers for Disease Control and Prevention. 2022. Influenza antiviral medications: summary for clinicians. https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm. Retrieved 21 February 2022."},{"key":"e_1_3_2_156_2","first-page":"461","article-title":"Zanamivir for the prevention of influenza in adults and children age 5 years and older","volume":"3","author":"Eiland LS","year":"2007","unstructured":"Eiland LS, Eiland EH. 2007. Zanamivir for the prevention of influenza in adults and children age 5 years and older. Ther Clin Risk Manag 3:461\u2013465.","journal-title":"Ther Clin Risk Manag"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2727"},{"key":"e_1_3_2_158_2","unstructured":"European Medicines Agency. 2019. Dectova (zanamivir). An overview of Dectova and why it is authorised in the EU. https:\/\/www.ema.europa.eu\/en\/documents\/overview\/dectova-epar-medicine-overview_en.pdf. Retrieved 3 April 2022."},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1038\/303041a0"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi0205449"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05026.x"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13040624"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00039"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05114"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.32607\/20758251-2009-1-2-26-32"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5560031007"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.21.9852"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1993.1461"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5560040606"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26040880"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-134"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0166-3542(00)00103-0"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054512"},{"key":"e_1_3_2_174_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3403-3408.2001"},{"key":"e_1_3_2_175_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0900648"},{"key":"e_1_3_2_176_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(02)00053-0"},{"key":"e_1_3_2_177_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00360-11"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1086\/318537"},{"key":"e_1_3_2_179_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.12.3809-3816.2002"},{"key":"e_1_3_2_180_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.03.003"},{"key":"e_1_3_2_181_2","unstructured":"World Health Organization. 2020. Summary of neuraminidase (NA) amino acid substitutions associated with reduced inhibition by neuraminidase inhibitors (NAIs). https:\/\/www.who.int\/publications\/m\/item\/summary-of-neuraminidase-(na)-amino-acid-substitutions-associated-with-reduced-inhibition-by-neuraminidase-inhibitors-(nais). Retrieved 4 March 2022."},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2019.03.019"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00645-06"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1309.070164"},{"key":"e_1_3_2_185_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.07.001"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.02.003"},{"key":"e_1_3_2_187_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104718"},{"key":"e_1_3_2_188_2","doi-asserted-by":"publisher","DOI":"10.1039\/d0ra07283d"},{"key":"e_1_3_2_189_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.11.018"},{"key":"e_1_3_2_190_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph15010028"},{"key":"e_1_3_2_191_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.10.008"},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2510.190607"},{"key":"e_1_3_2_193_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915341"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2022702"},{"key":"e_1_3_2_195_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27890-4"},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.87"},{"key":"e_1_3_2_197_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14009"},{"key":"e_1_3_2_198_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp400482a"},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep31500"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz418"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03026"},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz244"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53945-1"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2019.24.3.1800698"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0609-0"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2019.24.12.1900170"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104828"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2511.190757"},{"key":"e_1_3_2_209_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz908"},{"key":"e_1_3_2_210_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12821"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105369"},{"key":"e_1_3_2_212_2","unstructured":"World Health Organization. 2021. Summary of polymerase acidic (PA) protein amino acid substitutions analysed for their effects on baloxavir susceptibility. https:\/\/cdn.who.int\/media\/docs\/default-source\/influenza\/summary-of-polymerase-acidic-(pa)-protein-amino-acid-substitutions-analysed-for-their-effects-on-baloxavir-susceptibility.pdf. Retrieved 4 April 2022."},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01536"},{"key":"e_1_3_2_214_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1972769"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja204969m"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.01.006"},{"key":"e_1_3_2_217_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.9b00971"},{"key":"e_1_3_2_218_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b02196"},{"key":"e_1_3_2_219_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.8b00336"},{"key":"e_1_3_2_220_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00018"},{"key":"e_1_3_2_221_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-03840-9"},{"key":"e_1_3_2_222_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01327"},{"key":"e_1_3_2_223_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1016"},{"key":"e_1_3_2_224_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000786"},{"key":"e_1_3_2_225_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009356297"},{"key":"e_1_3_2_226_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00731-09"},{"key":"e_1_3_2_227_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038455"},{"key":"e_1_3_2_228_2","doi-asserted-by":"publisher","DOI":"10.1086\/656802"},{"key":"e_1_3_2_229_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2012.763104"},{"key":"e_1_3_2_230_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw255"},{"key":"e_1_3_2_231_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3189"},{"key":"e_1_3_2_232_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.0c00552"},{"key":"e_1_3_2_233_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00501-8"},{"key":"e_1_3_2_234_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.03.003"},{"key":"e_1_3_2_235_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107512"},{"key":"e_1_3_2_236_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.981-986.2005"},{"key":"e_1_3_2_237_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01217-18"},{"key":"e_1_3_2_238_2","unstructured":"Clinicaltrials.gov. 2010. Dose-finding study of favipiravir in the treatment of uncomplicated influenza. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01068912. Retrieved 19 February 2022."},{"key":"e_1_3_2_239_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.11.013"},{"key":"e_1_3_2_240_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz656"},{"key":"e_1_3_2_241_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104545"},{"key":"e_1_3_2_242_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811345115"},{"key":"e_1_3_2_243_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm5007275"},{"key":"e_1_3_2_244_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04623-14"},{"key":"e_1_3_2_245_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3212"},{"key":"e_1_3_2_246_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy547"},{"key":"e_1_3_2_247_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa376"},{"key":"e_1_3_2_248_2","unstructured":"Janssen. 2020. Janssen to discontinue pimodivir influenza development program. https:\/\/johnsonandjohnson.gcs-web.com\/static-files\/e175eddf-f6a7-47dd-9f72-34d25f69d13e. Retrieved 19 February 2022."},{"key":"e_1_3_2_249_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3244"},{"key":"e_1_3_2_250_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy410"},{"key":"e_1_3_2_251_2","unstructured":"Clinicaltrials.gov. 2018. The safety tolerability and pharmacokinetic study of ZSP1273 in healthy volunteers. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03679143. Retrieved 19 February 2022."},{"key":"e_1_3_2_252_2","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2021.1994944"},{"key":"e_1_3_2_253_2","unstructured":"Clinicaltrials.gov. 2020. A study of ZSP1273 tablets in patients with acute uncomplicated influenza A. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04683406. Retrieved 28 December 2022."},{"key":"e_1_3_2_254_2","doi-asserted-by":"publisher","DOI":"10.1177\/2040206618811416"},{"key":"e_1_3_2_255_2","doi-asserted-by":"publisher","DOI":"10.4149\/av_2018_211"},{"key":"e_1_3_2_256_2","unstructured":"Clinicaltrials.gov. 2020. Efficacy and safety of enisamium iodide for the treatment of acute respiratory viral infections including influenza. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04682444. Retrieved 19 February 2022."},{"key":"e_1_3_2_257_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02605-20"},{"key":"e_1_3_2_258_2","unstructured":"Clinicaltrials.gov. 2021. To evaluate the efficacy and safety of TG-1000 compared with placebo in adult patients with acute uncomplicated influenza virus infection. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04706468. Retrieved 19 February 2022."},{"key":"e_1_3_2_259_2","unstructured":"Clinicaltrials.gov. 2021. Evaluation the safety and tolerance of GP681 tablets in healthy subjects. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04729764. Retrieved 19 February 2022."},{"key":"e_1_3_2_260_2","unstructured":"Clinicaltrials.gov. 2021. A clinical study on the safety and efficacy of GP681 tablets in the treatment of uncomplicated acute influenza. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04736758. Retrieved 19 February 2022."},{"key":"e_1_3_2_261_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00057-15"},{"key":"e_1_3_2_262_2","doi-asserted-by":"publisher","DOI":"10.1038\/289366a0"},{"key":"e_1_3_2_263_2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1856814"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph14060587"},{"key":"e_1_3_2_265_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150227153919"},{"key":"e_1_3_2_266_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6221"},{"key":"e_1_3_2_267_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2014.04.015"},{"key":"e_1_3_2_268_2","unstructured":"Clinicaltrials.gov. 2011. Safety study of flufirvitide-3 nasal spray in healthy subjects. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01313962. Retrieved 19 February 2022."},{"key":"e_1_3_2_269_2","unstructured":"Clinicaltrials.gov. 2013. Safety tolerability and PK of escalating doses of flufirvitide-3 dry powder for inhalation in healthy subjects. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01990846. Retrieved 19 February 2022."},{"key":"e_1_3_2_270_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1617020114"},{"key":"e_1_3_2_271_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.04.006"},{"key":"e_1_3_2_272_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10040184"},{"key":"e_1_3_2_273_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.076612-0"},{"key":"e_1_3_2_274_2","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh201587188-96"},{"key":"e_1_3_2_275_2","unstructured":"Clinicaltrials.gov. 2018. Severe influenza trial of ARbidol (STAR). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03787459. Retrieved 19 February 2022."},{"key":"e_1_3_2_276_2","unstructured":"Clinicaltrials.gov. 2012. A study of arbidol (umifenovir) for treatment and prophylaxis of influenza and common cold (ARBITR). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01651663. Retrieved 20 February 2022."},{"key":"e_1_3_2_277_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3924"},{"key":"e_1_3_2_278_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0402486101"},{"key":"e_1_3_2_279_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2007.07.002"},{"key":"e_1_3_2_280_2","unstructured":"Clinicaltrials.gov. 2012. Testing the AVI-7100 flu drug in healthy volunteers. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01747148. Retrieved 19 February 2022."},{"key":"e_1_3_2_281_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13405"},{"key":"e_1_3_2_282_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.62.4.505"},{"key":"e_1_3_2_283_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.04.010"},{"key":"e_1_3_2_284_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc070359"},{"key":"e_1_3_2_285_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2015.10.009"},{"key":"e_1_3_2_286_2","first-page":"489","article-title":"Successful treatment of avian influenza with convalescent plasma","volume":"12","author":"Kong LK","year":"2006","unstructured":"Kong LK, Zhou BP. 2006. Successful treatment of avian influenza with convalescent plasma. Hong Kong Med J 12:489.","journal-title":"Hong Kong Med J"},{"key":"e_1_3_2_287_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-8-200610170-00139"},{"key":"e_1_3_2_288_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2907"},{"key":"e_1_3_2_289_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30253-X"},{"key":"e_1_3_2_290_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30199-7"},{"key":"e_1_3_2_291_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.3"},{"key":"e_1_3_2_292_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.05.005"},{"key":"e_1_3_2_293_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.06.004"},{"key":"e_1_3_2_294_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003942"},{"key":"e_1_3_2_295_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1502374112"},{"key":"e_1_3_2_296_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101207"},{"key":"e_1_3_2_297_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0592-z"},{"key":"e_1_3_2_298_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0206-5"},{"key":"e_1_3_2_299_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-214656"},{"key":"e_1_3_2_300_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00047"},{"key":"e_1_3_2_301_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41902"},{"key":"e_1_3_2_302_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13060965"},{"key":"e_1_3_2_303_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1205669"},{"key":"e_1_3_2_304_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3443"},{"key":"e_1_3_2_305_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00317"},{"key":"e_1_3_2_306_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.10.002"},{"key":"e_1_3_2_307_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.030"},{"key":"e_1_3_2_308_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay0678"},{"key":"e_1_3_2_309_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.09.018"},{"key":"e_1_3_2_310_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070739"},{"key":"e_1_3_2_311_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01027-20"},{"key":"e_1_3_2_312_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.06.002"},{"key":"e_1_3_2_313_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.3.1061"},{"key":"e_1_3_2_314_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.2001.1835"},{"key":"e_1_3_2_315_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.160.2.552"},{"key":"e_1_3_2_316_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.6.1785"},{"key":"e_1_3_2_317_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.128.241"},{"key":"e_1_3_2_318_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003057"},{"key":"e_1_3_2_319_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4168"},{"key":"e_1_3_2_320_2","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000518"},{"key":"e_1_3_2_321_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005702"},{"key":"e_1_3_2_322_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00607-16"},{"key":"e_1_3_2_323_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-17"},{"key":"e_1_3_2_324_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00352-20"},{"key":"e_1_3_2_325_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix292"},{"key":"e_1_3_2_326_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.073"},{"key":"e_1_3_2_327_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2017.08.007"},{"key":"e_1_3_2_328_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00694-18"},{"key":"e_1_3_2_329_2","unstructured":"Clinicaltrials.gov. 2017. Dose ranging study to evaluate the efficacy and safety of MEDI8852 in adults who are hospitalized with type A influenza. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03028909. Retrieved 19 February 2022."},{"key":"e_1_3_2_330_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02457-15"},{"key":"e_1_3_2_331_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.02.021"},{"key":"e_1_3_2_332_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.12.051"},{"key":"e_1_3_2_333_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104763"},{"key":"e_1_3_2_334_2","doi-asserted-by":"publisher","DOI":"10.1038\/217856a0"},{"key":"e_1_3_2_335_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.1.53"},{"key":"e_1_3_2_336_2","unstructured":"Clinicaltrials.gov. 2017. Flufenamic acid for hospitalised influenza infection. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03238612. Retrieved 19 February 2022."},{"key":"e_1_3_2_337_2","unstructured":"Clinicaltrials.gov. 2020. Efficacy of clarithromycin-naproxen-oseltamivir combination therapy vs. oseltamivir alone for hospitalised paediatric influenza patients. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04315194. Retrieved 19 February 2022."},{"key":"e_1_3_2_338_2","unstructured":"Clinicaltrials.gov. 2009. Oral triple combination antiviral drug therapy for treatment of influenza A in immunocompromised subjects (PO206). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00979251. Retrieved 19 February 2022."},{"key":"e_1_3_2_339_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0115-z"},{"key":"e_1_3_2_340_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.12.018"},{"key":"e_1_3_2_341_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08760"},{"key":"e_1_3_2_342_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.045"},{"key":"e_1_3_2_343_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00168-19"},{"key":"e_1_3_2_344_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033174"},{"key":"e_1_3_2_345_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11289"},{"key":"e_1_3_2_346_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13040667"},{"key":"e_1_3_2_347_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00550"},{"key":"e_1_3_2_348_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-015-0017-x"},{"key":"e_1_3_2_349_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-014-0179-8"},{"key":"e_1_3_2_350_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz163"},{"key":"e_1_3_2_351_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01020-2018"},{"key":"e_1_3_2_352_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01532-12"},{"key":"e_1_3_2_353_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53717-1.01337-8"},{"key":"e_1_3_2_354_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008320317"},{"key":"e_1_3_2_355_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00047-08"},{"key":"e_1_3_2_356_2","unstructured":"Clinicaltrials.gov. 2014. Treatment of severe influenza A infection. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02108366."},{"key":"e_1_3_2_357_2","unstructured":"Hung I To K Yuen K. 2019. Treatment of severe influenza a infection with Celecoxib: a double blind randomised controlled trial. https:\/\/rfs1.healthbureau.gov.hk\/images\/events\/HRS2019\/HRS2019_S17_powerpoint.pdf. Retrieved 29 December 2022."},{"key":"e_1_3_2_358_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp421"},{"key":"e_1_3_2_359_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu105"},{"key":"e_1_3_2_360_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis622"},{"key":"e_1_3_2_361_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.09.008"},{"key":"e_1_3_2_362_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00060"},{"key":"e_1_3_2_363_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00531"},{"key":"e_1_3_2_364_2","unstructured":"Clinicaltrials.gov. 2017. Efficiency of antagonist drugs of the cellular transcriptomic signature of influenza A virus infection (FLUNEXT). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03212716. Retrieved 21 February 2022."},{"key":"e_1_3_2_365_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12109"},{"key":"e_1_3_2_366_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911083116"},{"key":"e_1_3_2_367_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-020-0711-8"},{"key":"e_1_3_2_368_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1132505"},{"key":"e_1_3_2_369_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-102"},{"key":"e_1_3_2_370_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.06.032"},{"key":"e_1_3_2_371_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.01.025"},{"key":"e_1_3_2_372_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914561107"},{"key":"e_1_3_2_373_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003298"},{"key":"e_1_3_2_374_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00845-15"},{"key":"e_1_3_2_375_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02202-15"},{"key":"e_1_3_2_376_2","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c00568"},{"key":"e_1_3_2_377_2","doi-asserted-by":"publisher","DOI":"10.1038\/35099560"},{"key":"e_1_3_2_378_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04734"},{"key":"e_1_3_2_379_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603082103"},{"key":"e_1_3_2_380_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01410-12"},{"key":"e_1_3_2_381_2","unstructured":"Clinicaltrials.gov. 2017. Study examining PrEP-001 in healthy subjects. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03220048. Retrieved 20 February 2022."},{"key":"e_1_3_2_382_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.03.005"},{"key":"e_1_3_2_383_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1578"},{"key":"e_1_3_2_384_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2010.0071"},{"key":"e_1_3_2_385_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12094"},{"key":"e_1_3_2_386_2","unstructured":"Clinicaltrials.gov. 2010. Safety and efficacy study of interferon to treat patients hospitalized for influenza. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01227798. Retrieved 21 February 2022."},{"key":"e_1_3_2_387_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.679511"},{"key":"e_1_3_2_388_2","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh2017891066-70"},{"key":"e_1_3_2_389_2","unstructured":"Clinicaltrials.gov. 2020. Kagocel for the prevention of ARVI and influenza in adults health care workers. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04611061. Retrieved 20 February 2022."},{"key":"e_1_3_2_390_2","unstructured":"Clinicaltrials.gov. 2020. Kagocel for the prevention of ARVI and influenza in young people. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04626622. Retrieved 21 February 2022."},{"key":"e_1_3_2_391_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198712000-00009"},{"key":"e_1_3_2_392_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198807000-00011"},{"key":"e_1_3_2_393_2","doi-asserted-by":"publisher","DOI":"10.1159\/000150153"},{"key":"e_1_3_2_394_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198303000-00001"},{"key":"e_1_3_2_395_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000766"},{"key":"e_1_3_2_396_2","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2021.1918098"},{"key":"e_1_3_2_397_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0024-5"},{"key":"e_1_3_2_398_2","article-title":"Optimizing the detection of antiviral-resistant influenza-A strains using machine learning","author":"Shaltout N","year":"2016","unstructured":"Shaltout N, Rafea A, Moustafa A, Moustafa M, ElHefnawi M. 2016. Optimizing the detection of antiviral-resistant influenza-A strains using machine learning. In proceedings of the World Congress on Engineering and Computer Science. https:\/\/www.iaeng.org\/publication\/WCECS2016\/WCECS2016_pp527-532.pdf. Retrieved 29 December 2022.","journal-title":"In proceedings of the World Congress on Engineering and Computer Science"},{"key":"e_1_3_2_399_2","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab263"},{"key":"e_1_3_2_400_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-015-0472-9"},{"key":"e_1_3_2_401_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep40154"},{"key":"e_1_3_2_402_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55500"},{"key":"e_1_3_2_403_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu277"},{"key":"e_1_3_2_404_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-015-9641-z"},{"key":"e_1_3_2_405_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20915"},{"key":"e_1_3_2_406_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87845-0"},{"key":"e_1_3_2_407_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq480"},{"key":"e_1_3_2_408_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci500747n"},{"key":"e_1_3_2_409_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.7b00146"},{"key":"e_1_3_2_410_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-017-0235-x"},{"key":"e_1_3_2_411_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121277"},{"key":"e_1_3_2_412_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00110"},{"key":"e_1_3_2_413_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.08.002"},{"key":"e_1_3_2_414_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.05.002"},{"key":"e_1_3_2_415_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.970494"},{"key":"e_1_3_2_416_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4356-3"},{"key":"e_1_3_2_417_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389557515666150219145148"},{"key":"e_1_3_2_418_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.06.018"},{"key":"e_1_3_2_419_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050740"},{"key":"e_1_3_2_420_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19053018"},{"key":"e_1_3_2_421_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-016-9981-5"},{"key":"e_1_3_2_422_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936001-00001"},{"key":"e_1_3_2_423_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-018-0710-9"},{"key":"e_1_3_2_424_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa107"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00040-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00040-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T09:01:31Z","timestamp":1679562091000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00040-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":423,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3,23]]}},"alternative-id":["10.1128\/cmr.00040-22"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00040-22","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"2023-01-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00040-22"}}